Delivery Order SPE2DB20D2104-SPE2DB25FMPXJ

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,277.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,573.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,614.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of February 19, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,139.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award has an ultimate completion date of December 4, 2024 and is structured as a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement,...
This federal contract award, valued at $2,128.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $16,715.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure and heart failure. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,329.60 fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has a period of performance through September 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, with a ceiling value of $2,511.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of June 26, 2024 and is a Firm Fixed Price arrangement. This contract is not designated as a set-aside....
This is a federal contract award valued at $4,333.57 issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Defense agency (DLA Troop Support Medical) to the Amerisourcebergen Drug Corp's Corporate Office division. The $1,355.31 delivery order is for the supply of Telmisartan 80 mg tablets, a prescription medication used to treat high blood pressure. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMPXJ
    Delivery Order

This federal contract award, valued at $1,507.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure.

The contract has an ultimate completion date of May 2, 2025 and is a firm fixed-price delivery order. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/31/25, 10:03 AM